Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Kaiser Clinic and Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Abstract: Studies demonstrate that the use of nutritional supplements containing beta-glucans stimulates the immune system, modulates inflammatory activity, and promotes so-called immune training. Beta-glucans are prebiotics that stimulate the growth and activity of gastrointestinal microbiota and inhibit pathogen growth. Nutritional intervention is crucial for patients' positive evolution, and providing a supplement with highly bioavailable nutrients can make a difference in their nutritional, metabolic, and immune status. Therefore, the study aims to verify the effectiveness of the innate and adaptive immune response to a nutritionally balanced fermented food, containing oral or enteral beta-glucans, in patients treated at 3 Emergency Care Units in São José do Rio Preto, São Paulo, Brazil. This is a prospective randomized study with a characteristic design involving patients treated in the medical wards of 3 Emergency Care Unit. The following assessments will be conducted: Global Subjective Assessment for adults and Mini Nutritional Assessment for the elderly, Sociodemographic, and Laboratory Evaluation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | Placebo Comparator | The group will receive the intervention with coconut wheat |
|
| BioNutri AR-1 | Experimental | The group will receive the intervention with fermented and nutritionally balanced food |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BioNutri AR-1, | Dietary Supplement | intervention with fermented and nutritionally balanced food twice a day |
|
| Measure | Description | Time Frame |
|---|---|---|
| length of hospital stay | during hospitalization |
| Measure | Description | Time Frame |
|---|---|---|
| need for readmission | up to 24 weeks | |
| need for ICU | up to 24 weeks |
Not provided
Inclusion Criteria:
Patients admitted to the medical clinic ward
Exclusion Criteria:
Patients unable to swallow
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| FERNANDO SABIA TALLO, PhD | Contact | +55 11 971554018 | fstallo@unifesp.br |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018450 | Disease Progression |
| ID | Term |
|---|---|
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided